Seeds of change: simple diet hack may tame high blood fats
NCT ID NCT07004777
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding chia and pumpkin seeds to a standard healthy diet can lower triglyceride levels in people with hypertriglyceridemia. 375 adults with moderately high triglycerides will follow a balanced diet for 4 weeks, with half also eating seeds. The goal is to see if these affordable, traditional Mexican foods can improve blood fat levels and fatty acid profiles.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chia seeds and pumpkin seeds
- What this could lead to
- If it works, this could offer a simple, affordable dietary addition to help manage high triglycerides.
- What could go wrong
- This is a small, short-term dietary study (4 weeks) with no blinding, so results may not be strong or lasting. It only tests a specific diet, not a drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
RECRUITINGMexico City, Mexico City, 14080, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Plant-Based protein switch reshape your metabolism?
- Fish oil pills put to the test: can they tame high triglycerides?
- Weekly shot aims to tame dangerous fat levels in the blood
- Could ozempic stop pancreatitis from coming back?
- New shot aims to tame dangerous fat levels in blood
- New drug RBD5044 aims to lower high triglycerides in phase 2 trial